The Lancet: New Blood Test Predicts Which Covid-19 Patients Will Develop Severe Infection – Cath Lab Digest

Test could inform doctors on best treatment options
DUBLIN, Oct. 15, 2020: Scientists have developed, for the first time, a score that can accurately predict which patients will develop a severe form of Covid-19.
The study, led by researchers at RCSI University of Medicine and Health Sciences, is published in The Lancet’s translational research journal EBioMedicine.
The measurement, called the Dublin-Boston score, is designed to enable clinicians to make more informed decisions when identifyi…

Click here to view the original article.